Studies related to Cardiac Mass and Coenzyme Q10

Coenzyme Q10 (CoQ10) In Isolated Diastolic Heart Failure In Hypertrophic Cardiomyopathy (HCM)

Effect Decrease
Trial Design Non-controlled trial
Trial Length 6+ Months
Number of Subjects 41
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Notes for this study:
200mg CoQ10 daily alongside standard therapy (same in both groups) in persons with cardiohypertrophy was able to improve left ventricle and heart function while reducing the size of the left ventricle. Time of trial varied (9.4-27.5 months, mean length over a year)